Show simple item record

Targeted radiotherapy of brain tumours.

dc.contributor.author Zalutsky, MR
dc.coverage.spatial England
dc.date.accessioned 2015-12-03T18:30:42Z
dc.date.issued 2004-04-19
dc.identifier https://www.ncbi.nlm.nih.gov/pubmed/15083170
dc.identifier 6601771
dc.identifier.issn 0007-0920
dc.identifier.uri https://hdl.handle.net/10161/11048
dc.description.abstract The utility of external beam radiotherapy for the treatment of malignant brain tumours is compromised by the need to avoid excessive radiation damage to normal CNS tissues. This review describes the current status of targeted radiotherapy, an alternative strategy for brain tumour treatment that offers the exciting prospect of increasing the specificity of tumour cell irradiation.
dc.language eng
dc.publisher Springer Science and Business Media LLC
dc.relation.ispartof Br J Cancer
dc.relation.isversionof 10.1038/sj.bjc.6601771
dc.subject Antibodies, Monoclonal
dc.subject Astrocytoma
dc.subject Brain Neoplasms
dc.subject Clinical Trials as Topic
dc.subject Glioblastoma
dc.subject Humans
dc.subject Radiation Injuries
dc.subject Radioimmunotherapy
dc.title Targeted radiotherapy of brain tumours.
dc.type Journal article
duke.contributor.id Zalutsky, MR|0095795
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/15083170
pubs.begin-page 1469
pubs.end-page 1473
pubs.issue 8
pubs.organisational-group Clinical Science Departments
pubs.organisational-group Duke
pubs.organisational-group Duke Cancer Institute
pubs.organisational-group Institutes and Centers
pubs.organisational-group Pathology
pubs.organisational-group Radiation Oncology
pubs.organisational-group Radiology
pubs.organisational-group School of Medicine
pubs.publication-status Published
pubs.volume 90


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record